Lung disease Clinical Trials
Recruiting lung disease studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat lung disease. Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting lung disease studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting lung disease trials
Chronic COUGH Management in Interstitial Lung DisEase
RSV Vaccination to Reduce Recurrent AECOPD
Antigen-specific T Cells Against Lung Cancer
Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical Records
Pulmonary Rehabilitation Frequency in COPD Patients
Witness Project Lung
Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )
Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines
GLP-1/GIP Receptor Agonists in Obesity-Related HFpEF: The GLIDE-HF Registry
SMART-School-based Asthma Therapy
Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery
Bridge to Lung Transplant With Trans-septal Extra-corporeal Membrane Oxygenation (ECMO) for Right Heart Failure From Pulmonary Hypertension
The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD
Effect of add-on Doxofylline on Lung Function in Stable COPD
Portable Positive Pressure Therapy Device
Effect on Bronchodilation Response and Ventilation Heterogeneity of Different Inhalation Volumes in COPD
Ginger's Therapeutic Potential in Asthma
Prospective Multiomic Analysis in Small-Cell Lung Cancer
A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)
An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial
Structured Nursing Intervention for Adults With Poorly Controlled Asthma: A Pilot Study
Analysis of Breath Volatile Organic Compounds Using Mass Spectrometry
Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib
A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma
THERMotherapy Against Persistent Bacterial LUNG Infections
Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Interstitial Lung Disease
Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer
Testing the SurVaxM Vaccine for Lung Cancer Prevention
Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants
Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Feasibility of Noninvasive Trigeminal Nerve Stimulation During Exercise
Myocardial Metabolic Flux in Pulmonary Arterial Hypertension
Asthma Lung Sounds With Wearable Stethoscope
Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)
Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC
Novel Method for Removal of Orally Deposited Inhaled Fluticasone Propionate
Withdrawal of Prostacyclin Pathway Therapy in Patients With Pulmonary Arterial Hypertension Receiving Sotatercept (WATERLOO)
Artificially Intelligent Robot Control
Self-Help Booklets for Sleep in Adults With Pulmonary Hypertension
Understanding the Effects of Pulmonary Arterial Hypertension on Lean Muscle Mass-Substudy
Blood Cell Count Derived Inflammatory Indexes in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Family-centred Pulmonary Rehabilitation to Empower Carers
Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
Home-Based Respiratory Muscle Training and Aerobic Exercise Programs to Improve Lung Health in Current and Former Cigarette Smokers
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
CS1 Added to Standard of Care Therapy for Pulmonary Arterial Hypertension
A Study of a Side Effects and Resource Navigation Program for People With Cancer
A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT Imaging
Pulmonary Hypertension (PH) Biorepository for Translational Research
Vapor Ablation for Localized Cancer Lesions
Developing an Intervention to Optimize Virtual Care Adoption for COPD Management
Clinical Trial of 2-HOBA in Pulmonary Arterial Hypertension
Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea in Patients With Chronic Respiratory Disease: a Randomized Cross-over Trial
A New Way to Share Radiation Therapy Plans Between Doctors, CORRECT Trial
Immuno-inflammatory Response of Erdosteine in COPD
New trials in Birmingham, AL?
Pick a condition and we'll email you once a week when a new study starts recruiting in Birmingham, AL. Unsubscribe anytime.
Lung disease clinical trials — common questions
Are lung disease clinical trials free to join?
Yes. Participating in a lung disease clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a lung disease clinical trial?
Each lung disease study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a lung disease trial near me?
Use the location controls above. We'll show recruiting lung disease trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many lung disease trials are recruiting right now?
We're currently tracking roughly 561 recruiting lung disease trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.